ABOUT OWNMED INNOVATION
Medical solutions
for the future
Ownmed Innovation is a MedTech spin-off company based in Madrid, Spain. It was established through the strategic alliance between the Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (FIBHGM), the Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), and the Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®, designed to improve continence management for ostomized individuals, aiming to transform healthcare through innovation, efficiency, and a patient-centered approach.
2021
FOUNDED
Madrid
HEADQUARTERS
ABOUT OWNMED INNOVATION
Medical solutions
for the future
Ownmed Innovation is a MedTech spin-off company based in Madrid, Spain. It was established through the strategic alliance between the Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (FIBHGM), the Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), and the Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®, designed to improve continence management for ostomized individuals, aiming to transform healthcare through innovation, efficiency, and a patient-centered approach.
2021
FOUNDED
Madrid
HEADQUARTERS
Meet our team

Ana Ye leads the strategy and executive direction of Ownmed Innovation, overseeing operations, managing resources, and fostering institutional relationships. With a background in nursing, biomedical engineering, and an MBA, Ana addresses the challenges of the healthcare technology sector from a comprehensive perspective. She is responsible for developing new applications, securing funding, and maintaining close relationships with investors. Her strategic vision and decision-making skills have driven the company's growth, with a focus on innovation and product development.
Ana's leadership has been recognized in the business world, earning her the Female Startups Leaders award in 2024 and being named the second finalist in the 2024 Princess of Girona Awards in the "Crea Empresa" category.
- ana.ye@ownmedinnovation.com

Dr. Desco, with an extensive background in bioengineering and medicine, is a professor at UC3M, Director of the Innovation Support Unit at Hospital Gregorio Marañón, and Head of the Experimental Medicine and Surgery Unit at the same hospital. Additionally, he leads the Advanced Imaging Unit at the National Center for Cardiovascular Research (CNIC). He brings his expertise in innovation and technology transfer from the healthcare sector. He has created over 30 patents and led numerous projects that have resulted in successful commercial products.
His role at Ownmed focuses on providing scientific guidance and connecting with key institutions to promote the development of innovative medical solutions.

A recognized oncologist (included in the Forbes 2023 list of the top 100 doctors in Spain), Dr. García-Foncillas leads the “Oncohealth” Oncology Institute of the Quirón Group and is the Head of the Oncology Department at Fundación Jiménez Díaz Hospital. Additionally, he is a Professor of Oncology at the Autonomous University in Madrid His expertise in translational oncology and leadership in molecular personalized medicine strengthen Ownmed's scientific strategy. He is actively involved in key associations and is a leading figure in oncological research, having published over 220 articles.
His vision drives excellence in the development of advanced medical solutions.

- ana.ye@ownmedinnovation.com
Ana Ye leads the strategy and executive direction of Ownmed Innovation, overseeing operations, managing resources, and fostering institutional relationships. With a background in nursing, biomedical engineering, and an MBA, Ana addresses the challenges of the healthcare technology sector from a comprehensive perspective. She is responsible for developing new applications, securing funding, and maintaining close relationships with investors. Her strategic vision and decision-making skills have driven the company's growth, with a focus on innovation and product development.
Ana's leadership has been recognized in the business world, earning her the Female Startups Leaders award in 2024 and being named the second finalist in the 2024 Princess of Girona Awards in the "Crea Empresa" category.
- ana.ye@ownmedinnovation.com

Dr. Desco, with an extensive background in bioengineering and medicine, is a professor at UC3M, Director of the Innovation Support Unit at Hospital Gregorio Marañón, and Head of the Experimental Medicine and Surgery Unit at the same hospital. Additionally, he leads the Advanced Imaging Unit at the National Center for Cardiovascular Research (CNIC). He brings his expertise in innovation and technology transfer from the healthcare sector. He has created over 30 patents and led numerous projects that have resulted in successful commercial products.
His role at Ownmed focuses on providing scientific guidance and connecting with key institutions to promote the development of innovative medical solutions.

A recognized oncologist (included in the Forbes 2023 list of the top 100 doctors in Spain), Dr. García-Foncillas leads the “Oncohealth” Oncology Institute of the Quirón Group and is the Head of the Oncology Department at Fundación Jiménez Díaz Hospital. Additionally, he is a Professor of Oncology at the Autonomous University in Madrid His expertise in translational oncology and leadership in molecular personalized medicine strengthen Ownmed's scientific strategy. He is actively involved in key associations and is a leading figure in oncological research, having published over 220 articles.
His vision drives excellence in the development of advanced medical solutions.
With over 25 years of experience in accounting, taxation, and financial advisory for small and medium-sized enterprises, Joaquín Solanes is the director of Servicios Profesionales Integrados (SPI) Asesoría de Empresas S.L. He specializes in business tax planning, financial reporting, risk management, and investment opportunity evaluation.
His strategic approach and expertise in the financial sector enable Ownmed to optimize resources and assess investment opportunities, ensuring sustainable growth.

Alfredo, an industrial engineer specialized in mechanics, has over 15 years of experience in design and project management in the aeronautical, home appliance and medical device sectors. He leads the technical development of Ostofix, from the conceptual phase to production, ensuring compliance with quality and safety standards. He oversees the continuous improvement of prototypes and coordinates with manufacturers. His responsibilities also include the implementation of new technologies and the planning of the long-term technological strategy.
- alfredo.azabal@ownmedinnovation.com

Dr. Marta Casarrubios is a pharmacist with a PhD in Biomedical Sciences. She specializes in oncology and immunotherapy, with over 6 years of experience in clinical trials. She has worked in translational research at the Dana-Farber Cancer Institute and has expertise in molecular biomarkers. Additionally, she has experience in data analysis, scientific writing, and R&D project management.
At Ownmed, she will be responsible for the scientific aspects, leading the clinical development of Ostofix and ensuring its technical and regulatory validation.
- m.casarrubios@ownmedinnovation.com

Mónica Portela is a Biomedical Engineer with a master's degree in Nanotechnology from the University of Twente and is currently an industrial PhD candidate. She has experience as a clinical trials monitor, overseeing daily execution, data validation, and training of clinical staff.
At Ownmed Innovation, she will lead, alongside the CSO, the clinical aspects of the Ostofix project, managing tests and collaborations to advance its development and validation.
- m.portela@ownmedinnovation.com

Ownmed Innovation is a MedTech spin-off company based in Madrid, Spain. Founded on June 24, 2021, the company specializes in developing advanced medical technologies aimed at improving healthcare delivery and enhancing patient well-being.

Ownmed Innovation is a MedTech spin-off company based in Madrid, Spain. Founded on June 24, 2021, the company specializes in developing advanced medical technologies aimed at improving healthcare delivery and enhancing patient well-being.
Ownmed is supported by a multidisciplinary team of experts in healthcare, engineering, and business, who collaborate to drive innovation and deliver impactful solutions for patients and healthcare providers alike.

